These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18855716)

  • 1. The role of trimetazidine after acute myocardial infarction.
    Banach M; Rysz J; Goch A; Mikhailidis DP; Rosano GM
    Curr Vasc Pharmacol; 2008 Oct; 6(4):282-91. PubMed ID: 18855716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimetazidine in the Prevention of Tissue Ischemic Conditions.
    Kallistratos MS; Poulimenos LE; Giannitsi S; Tsinivizov P; Manolis AJ
    Angiology; 2019 Apr; 70(4):291-298. PubMed ID: 29888611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimetazidine for stable angina.
    Ciapponi A; Pizarro R; Harrison J
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003614. PubMed ID: 16235330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
    Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
    Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WITHDRAWN: Trimetazidine for stable angina.
    Ciapponi A; Pizarro R; Harrison J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD003614. PubMed ID: 28319269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina.
    Danchin N
    Am J Cardiol; 2006 Sep; 98(5A):8J-13J. PubMed ID: 16931200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous morphine and chest pain.
    Conti CR
    Clin Cardiol; 2011 Aug; 34(8):464-5. PubMed ID: 21812007
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
    Wu L; Luan Y; Li Y; Wang M; He J; Jin C; Zhang W
    BMC Cardiovasc Disord; 2020 Jun; 20(1):273. PubMed ID: 32503494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modulation of myocardial metabolism with trimetazidine].
    Kölbel F
    Vnitr Lek; 2006 Jun; 52(6):558-9. PubMed ID: 16871756
    [No Abstract]   [Full Text] [Related]  

  • 13. Trimetazidine for stable angina pectoris.
    Cross HR
    Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of metabolically active drugs in the management of ischemic heart disease.
    Schofield RS; Hill JA
    Am J Cardiovasc Drugs; 2001; 1(1):23-35. PubMed ID: 14728049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Wang C; Chen W; Yu M; Yang P
    Angiology; 2021 Jul; 72(6):511-523. PubMed ID: 33472383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)].
    Chaloupka V
    Vnitr Lek; 2006 Jun; 52(6):609-14. PubMed ID: 16871765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antianginal drugs in stable angina on predicted mortality risk after surviving a myocardial infarction: a preliminary study (METRO).
    Iyengar SS; Rosano GM
    Am J Cardiovasc Drugs; 2009; 9(5):293-7. PubMed ID: 19791838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic and metabolic agents in the treatment of stable angina: publication review.
    Jackson G
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S22-4. PubMed ID: 11286303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
    Stanley WC; Marzilli M
    Fundam Clin Pharmacol; 2003 Apr; 17(2):133-45. PubMed ID: 12667223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.